Outsourcing Innovation eBook
Read the article:
Preparing for a New Wave of mRNA Technologies
Read the eBook:
Pharmaceutical Technology’s Outsourcing Innovation eBook
To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
BillionPhotos.com/Stock.adobe.com
The ability of the biopharma industry to meet the worldwide demand for messenger RNA vaccines was facilitated by contract development and manufacturing organizations. These partners promptly adapted their facilities and capabilities specifically for vaccine production, offering contract fill/finish and cold chain services required to meet demand. Examining the lessons learned from the COVID-19 pandemic, this article provides a perspective on the strategies and tactics taken to deliver a better drug development program and highlights the importance of remembering key lessons as the industry moves toward an era of new drug modalities.
Read this article in Pharmaceutical Technology’s February 2023 Outsourcing Innovation eBook.
Read the article:
Preparing for a New Wave of mRNA Technologies
Read the eBook:
Pharmaceutical Technology’s Outsourcing Innovation eBook
Jeong Jin-hyeok is a lead specialist in drug product at Samsung Biologics.
Pharmaceutical Technology
eBook: Outsourcing Innovation, February 2023
February 2023
Pages: 30–32
When referring to this article, please cite it as J. Jin-hyeok, “Preparing for a New Wave of mRNA Technologies," Pharmaceutical Technology Outsourcing Innovation eBook (February 2023).
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.